Navigation Links
Lancet Blames CMA For Dismissal Of Editors

The Canadian Medical Association (CMA) has been criticized by Lancet, one of the world's leading journals in the field of medicine regarding dismissal of the editor (Dr. John Hoey) and deputy editor// (Anne Marie Todkill) of Canadian Medical Association Journal. The Lancet editors, in the latest issue of the journal have remarked the issue as 'deeply troubling'.

'Medical journals have a long history of investigative journalism through which they perform an important watchdog function by challenging the forces that undermine the values of medicine. What seems to be an attempt by the CMA to deprive editors of the capacity to bring to account those responsible for the perverse consequences of badly implemented policy or wrongheaded principles is deeply troubling,' the editorial reads.

The journal's publisher had asked the editors to withhold an article related to the experiences of women in trying to get hold of the morning-after pill, last week. This could have prompted for the spark of editorial interference. An attenuated version of the controversial article was however, published by the CMAJ.

The editors were dismissed on the 20th of February. The dismissal is perceived as an attempt to introduce new leadership to the CMAJ. Others believe that interference in editorial autonomy could have been responsible for the firing. Moreover, it is even regarded as an attempt to deprive the pursuit of investigative journalism, by the CMAJ.

A complaint was filed, in response to which the CMA argued that the publication was not based on true scientific evidence. In light of the above situation, may it is time for medical professionals to come to a universal agreement regarding issues related to editorial rights or rather autonomy.


'"/>




Page: 1

Related medicine news :

1. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
2. Lancet Urges To Allow Emergency Contraception Drug As An OTC
3. More Than £500m Wasted On Drugs; MP Blames NH
4. US President Blames Birthday Cakes for Weight Gain
5. Delhi High Court Blames Government Inaction on Dengue Outbreak
6. Ramadoss Blames State Governments for High Dengue Toll
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! God’s ... to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A Story ... couple from Long Island, New York. , Published by Christian Faith Publishing, Dale Anthony ...
(Date:8/18/2017)... ... ... ... For Immediate Release                Contact: Julian Teixeira, August ... Seek Sex and Relationship Advice from their Fathers , ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a Missouri-based ... drive to generate community support for efforts to educate the local population on cancer ... all types of cancer. , Each day in America, roughly 4,600 new cases ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017   Mostyn Law and Gulf ... Houston, Texas . The Mostyn Law family ... 2 years. That is why Mostyn Law is partnering ... to show its appreciation. Blood supplies are running ... 5% short of hospital needs in August. That is why the ...
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: